ProAssurance Completes Merger, Delists from NYSE as Wholly Owned Subsidiary
Summary
ProAssurance Corporation has completed its merger with The Doctors Company, becoming a private entity, with shareholders receiving $25.00 per share in cash.
Key Events · M&A and Partnerships · PRA
-
Merger Completed
ProAssurance Corporation has been acquired by The Doctors Company, becoming a wholly owned subsidiary as of June 26, 2026. This follows the 8-K filed on June 23, 2026, which announced the merger was expected to close today.
-
Cash Payout to Shareholders
Each outstanding share of ProAssurance Common Stock was converted into the right to receive $25.00 in cash, without interest. Restricted stock units, performance shares, and deferred compensation accounts were also converted into cash at this rate.
-
Delisting and Deregistration
ProAssurance notified the NYSE to suspend trading and delist its common stock. The company intends to terminate its registration under Section 12(g) and suspend its reporting obligations with the SEC.
-
Board and Officer Changes
All previous directors and officers of ProAssurance ceased their roles upon the merger's effective time and were immediately replaced by new appointments from The Doctors Company.
Analysis · PRA · Finance
This filing confirms the completion of the merger where ProAssurance Corporation has been acquired by The Doctors Company. As a result, ProAssurance is now a wholly owned subsidiary, its common stock has been converted into cash at $25.00 per share, and it will be delisted from the NYSE. This marks the end of ProAssurance as a publicly traded entity, fundamentally altering its investment thesis.
At the time of this filing, PRA was trading at $25.02 on NYSE in the Finance sector, with a market capitalization of approximately $1.3B. This filing was assessed with neutral market sentiment and an importance score of 10 out of 10.